Pentasa Cr Indications, Dosage, Storage, Stability - Mesalamine CR

Pentasa Cr Indications, Dosage, Storage, Stability - Mesalamine CR

INDICATIONS

PENTASA is indicated for the induction of remission and for the treatment of patients with mildly to moderately active ulcerative colitis.

DOSAGE AND ADMINISTRATION

The recommended dosage for the induction of remission and the symptomatic treatment of mildly to moderately active ulcerative colitis is 1 g (4 PENTASA capsules) four times a day for a total daily dose of 4g. Treatment duration in controlled trials was up to 8 weeks.

HOW SUPPLIED

PENTASA controlled-release capsules are supplied in bottles of 240 capsules (NDC 54092-189-81); and blister packs of 80 capsules (NDC 54092-189-80). Each green and blue capsule contains 250 mg of mesalamine in controlled-release beads. PENTASA controlled-release capsules are identified with a pentagonal starburst logo and the number 2010 on the green portion and PENTASA 250 mg on the blue portion of the capsules.

Store at controlled room temperature 59° to 86°F(15° to 30°C).